Table 1.
Study cohort
| Controls | PBB | CSLD | |
|---|---|---|---|
| Number of children | 10 | 28 | 40 (36 with BE) |
| Region | |||
| Brisbane | 10 | 28 | 5 (all with BE) |
| Darwin | 0 | 0 | 35 (31 with BE) |
| Median age in years (95 % CI) | 2.0 (1.0–4.0) | 1.8 (1.4–2.3) | 2.6 (2.1–3.1) |
| Number of Indigenous children (%) | 0 (0) | 2 (7) | 33 (83) |
| Males (%) | 8 (80) | 16 (57) | 23 (58) |
| Received antibiotics within 2 weeks of bronchoscopy (%) | 2 (20) | 6 (21) | 26 (65) |
| Azithromycin | 1 | 1 | 17 |
| Amoxicillin | 0 | 0 | 1 |
| Amoxicillin clavulanate | 1 | 3 | 1 |
| Sulfamethoxazole trimethoprim | 0 | 2 | 1 |
| Roxithromycin | 0 | 0 | 1 |
| Ceftriaxone | 0 | 0 | 2 |
| Azithromycin + sulphamethoxazole trimethoprim | 0 | 0 | 1 |
| Ceftriaxone, amoxicillin clavulanate, flucloxicillin | 0 | 0 | 1 |
| Unsure if received antibiotics | 0 | 0 | 1 |
BE idiopathic bronchiectasis